Peter Heerma
Chief Commercial OfficerMr. Peter Heerma serves as Chief Commercial Officer of Travere Therapeutics, Inc. (formerly known as Retrophin, Inc.) since October 01, 2019. Mr. Heerma served as global product general manager for oncology and cardiovascular products at Amgen Inc. from December 2015 to September 2019. From December 2003 until November 2015, Mr. Heerma held roles of increasing responsibility at Abbott Laboratories (“Abbott”), and following Abbott’s spin-off of AbbVie, Inc. He served as senior director of Portfolio strategy for hepatology and nephrology, as well as senior director and asset team lead for HCV, diabetic nephropathy and neuroscience development projects at AbbVie Inc. He served as Director of Commercial Strategy Renal Care, International Marketing Director, Business Unit Manager of hospital products, and Product Manager for obesity and cardiovascular products at Abbott Laboratories. He holds a Master of Science in European Business Administration and Business Law from the Lund University in Sweden and a Bachelor of Science in Retail Management and Marketing from Stenden University in the Netherlands.
Positions
- Company NameTravere Therapeutics, Inc.Stock CodeTVTXPositionChief Commercial OfficerColleagues
- EMEric M. DubePresident, CEO & Director
- GAGary A. LyonsIndependent Chairman of the Board
- CCChristopher ClineChief Financial Officer
- WEWilliam E. RoteChief Research Officer
- JIJula InrigExecutive VP, Head of Research & Development and Chief Medical Officer
- JAJeffrey A. MecklerIndependent Director
- TPTimothy P. CoughlinIndependent Director
- JAJohn A. OrwinIndependent Director
